DEXTRIN HYDROGEL FOR BIOMEDICAL APPLICATIONS

A hydrogel formulation of oxidized dextrin is reticulated with adipic acid dihydrazide, which may embody polysaccharides, proteins, nanogels, granular materials, bioactive molecules and cells for tissue regeneration and controlled drug delivery. A hydrogel can be injectable, highly biocompatible and...

Full description

Saved in:
Bibliographic Details
Main Authors MAIO MOLINOS, MARIA CABRAL, PORTELA DA GAMA, FRANCISCO MIGUEL
Format Patent
LanguageEnglish
French
German
Published 30.09.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A hydrogel formulation of oxidized dextrin is reticulated with adipic acid dihydrazide, which may embody polysaccharides, proteins, nanogels, granular materials, bioactive molecules and cells for tissue regeneration and controlled drug delivery. A hydrogel can be injectable, highly biocompatible and biodegradable, for tissue regenerative applications, performing simultaneously as a vehicle e.g. for nanogels, granular materials and cells, and as controlled drug delivery systems, e.g. of hydrophobic molecules and therapeutic proteins.
Bibliography:Application Number: EP20100809176